Medscape Nephrology Editorial Board

Editorial Board — Medscape Nephrology

Board Members

Rajiv Agarwal, MD
- Indiana University School of Medicine
  Indiana University
  Indianapolis, Indiana
Richard A. Sherman, MD
- Professor Emeritus
  Robert Wood Johnson Medical School
  New Brunswick, New Jersey

Matthew R. Weir, MD
- University of Maryland School of Medicine
  Baltimore, Maryland
F. Perry Wilson, MD, MSCE
- Yale School of Medicine
  New Haven, Connecticut

Board Member Details

Rajiv Agarwal, MD

Professor of Medicine, Indiana University School of Medicine, Indianapolis, Indiana

Rajiv Agarwal, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: AstraZeneca; Ironwood Pharmaceuticals; Akebia; Bayer; Janssen; Glaxo Smith Kline; Relypsa; Sanofi; Genzyme; Boehringer Ingelheim; BirdRock Bio; Celgene; Daiichi Sanyko, Inc.; Eli Lilly; Reata; Takeda Pharmaceuticals; ZS Pharma
Received income in an amount equal to or greater than $250 from: AstraZeneca; Ironwood Pharmaceuticals; Akebia; Bayer; Janssen; Glaxo Smith Kline; Relypsa; Sanofi; Genzyme; Boehringer Ingelheim; BirdRock Bio; Celgene; Daiichi Sanyko, Inc.; Eli Lilly; Reata; Takeda Pharmaceuticals; ZS Pharma
Serve(d) as an author for: UpToDate
Serve(d) as an editor for: American Journal of Nephrology; Nephrology Dialysis and Transplantation

[ Back to Top ]

Richard A. Sherman, MD

Professor Emeritus, Robert Wood Johnson Medical School, New Brunswick, New Jersey

Richard A. Sherman, MD, has disclosed no relevant financial relationships.

[ Back to Top ]

Matthew R. Weir, MD

Professor of Medicine; Director, Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland

Matthew R. Weir, MD, has disclosed the following relevant financial relationships:
Serve(d) as an advisory or consultant for: MSD; Boehringer Ingelheim; AztraZeneca; Relypsa; Vifor; Boston Scientific; AbbVie; Janssen; Bayer; Reata

[ Back to Top ]

F. Perry Wilson, MD, MSCE

Assistant Professor, Department of Medicine; Interim Director, Program of Applied Translational Research, Yale School of Medicine, New Haven, Connecticut

F. Perry Wilson, MD, MSCE, has disclosed no relevant financial relationships.

[ Back to Top ]